Status:

COMPLETED

The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity

Lead Sponsor:

Radboud University Medical Center

Conditions:

Diabetes

Hypoglycemia Unawareness

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

Hypoglycaemia unawareness is a common complication in patients with type 1 diabetes and with insulin-treated type 2 diabetes of long duration. The loss of autonomic symptoms to hypoglycemia does not s...

Eligibility Criteria

Inclusion

  • Informed consent
  • Homozygous for Arginine at codon 16 or homozygous Gly at codon 16
  • No regular usage of medication other than oral contraceptives

Exclusion

  • History of cerebrovascular, cardiovascular, or peripheral vascular disease
  • Smoking
  • Alcohol usage of more than 10 units per week
  • Inability to abstain from xanthine-derivatives (coffee, tea, cola, chocolate, cacao) or alcohol for 2 days
  • BMI above 30 kg/m2
  • Participation to any other trial in the preceding 3 months
  • Ongoing disease of any kind
  • Pregnancy

Key Trial Info

Start Date :

April 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2009

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT00160056

Start Date

April 1 2005

End Date

April 1 2009

Last Update

May 12 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Radboud University Nijmegen Medical Centre

Nijmegen, Gelderland, Netherlands, 6500HB

The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity | DecenTrialz